Institutional investors hold a majority ownership of CELG through the 80.58% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2017, these large investors purchased a net $36.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 10.1 Million shares of Celgene Corp
JACKSON SQUARE PARTNERS LLC Bought 5.7 Million shares of Celgene Corp
CITADEL ADVISORS LLC Bought 3.7 Million shares of Celgene Corp